TARGINIQ Drug Patent Profile
✉ Email this page to a colleague
When do Targiniq patents expire, and when can generic versions of Targiniq launch?
Targiniq is a drug marketed by Purdue Pharma Lp and is included in one NDA. There are two patents protecting this drug.
This drug has one hundred and fifty-one patent family members in forty-one countries.
The generic ingredient in TARGINIQ is naloxone hydrochloride; oxycodone hydrochloride. There are twelve drug master file entries for this compound. Additional details are available on the naloxone hydrochloride; oxycodone hydrochloride profile page.
DrugPatentWatch® Generic Entry Outlook for Targiniq
By analyzing the patents and regulatory protections it appears that the earliest date
for generic entry will be March 30, 2025. This may change due to patent challenges or generic licensing.
There have been twenty-six patent litigation cases involving the patents protecting this drug, indicating strong interest in generic launch. Recent data indicate that 63% of patent challenges are decided in favor of the generic patent challenger and that 54% of successful patent challengers promptly launch generic drugs.
Indicators of Generic Entry
Summary for TARGINIQ
International Patents: | 151 |
US Patents: | 2 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 5 |
Patent Applications: | 10 |
Formulation / Manufacturing: | see details |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for TARGINIQ |
What excipients (inactive ingredients) are in TARGINIQ? | TARGINIQ excipients list |
DailyMed Link: | TARGINIQ at DailyMed |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for TARGINIQ
Generic Entry Date for TARGINIQ*:
Constraining patent/regulatory exclusivity:
NDA:
Dosage:
TABLET, EXTENDED RELEASE;ORAL |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Anatomical Therapeutic Chemical (ATC) Classes for TARGINIQ
US Patents and Regulatory Information for TARGINIQ
TARGINIQ is protected by two US patents.
Based on analysis by DrugPatentWatch, the earliest date for a generic version of TARGINIQ is ⤷ Try a Trial.
This potential generic entry date is based on patent ⤷ Try a Trial.
Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.
Patents protecting TARGINIQ
Oxycodone hydrochloride having less than 25 PPM 14-hydroxycodeinone
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Oxycodone compositions
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Purdue Pharma Lp | TARGINIQ | naloxone hydrochloride; oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 205777-001 | Jul 23, 2014 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Purdue Pharma Lp | TARGINIQ | naloxone hydrochloride; oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 205777-002 | Jul 23, 2014 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Purdue Pharma Lp | TARGINIQ | naloxone hydrochloride; oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 205777-001 | Jul 23, 2014 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Purdue Pharma Lp | TARGINIQ | naloxone hydrochloride; oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 205777-002 | Jul 23, 2014 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Purdue Pharma Lp | TARGINIQ | naloxone hydrochloride; oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 205777-003 | Jul 23, 2014 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Purdue Pharma Lp | TARGINIQ | naloxone hydrochloride; oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 205777-003 | Jul 23, 2014 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for TARGINIQ
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Purdue Pharma Lp | TARGINIQ | naloxone hydrochloride; oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 205777-001 | Jul 23, 2014 | ⤷ Try a Trial | ⤷ Try a Trial |
Purdue Pharma Lp | TARGINIQ | naloxone hydrochloride; oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 205777-003 | Jul 23, 2014 | ⤷ Try a Trial | ⤷ Try a Trial |
Purdue Pharma Lp | TARGINIQ | naloxone hydrochloride; oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 205777-003 | Jul 23, 2014 | ⤷ Try a Trial | ⤷ Try a Trial |
Purdue Pharma Lp | TARGINIQ | naloxone hydrochloride; oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 205777-002 | Jul 23, 2014 | ⤷ Try a Trial | ⤷ Try a Trial |
Purdue Pharma Lp | TARGINIQ | naloxone hydrochloride; oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 205777-002 | Jul 23, 2014 | ⤷ Try a Trial | ⤷ Try a Trial |
Purdue Pharma Lp | TARGINIQ | naloxone hydrochloride; oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 205777-003 | Jul 23, 2014 | ⤷ Try a Trial | ⤷ Try a Trial |
Purdue Pharma Lp | TARGINIQ | naloxone hydrochloride; oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 205777-003 | Jul 23, 2014 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for TARGINIQ
When does loss-of-exclusivity occur for TARGINIQ?
Based on analysis by DrugPatentWatch, the following patents block generic entry in the countries listed below:
African Regional IP Organization (ARIPO)
Patent: 32
Estimated Expiration: ⤷ Try a Trial
Argentina
Patent: 9012
Estimated Expiration: ⤷ Try a Trial
Patent: 8531
Estimated Expiration: ⤷ Try a Trial
Patent: 4161
Estimated Expiration: ⤷ Try a Trial
Australia
Patent: 05230826
Estimated Expiration: ⤷ Try a Trial
Patent: 09200335
Estimated Expiration: ⤷ Try a Trial
Patent: 11213801
Estimated Expiration: ⤷ Try a Trial
Patent: 13202453
Estimated Expiration: ⤷ Try a Trial
Patent: 15261590
Estimated Expiration: ⤷ Try a Trial
Patent: 17204741
Estimated Expiration: ⤷ Try a Trial
Austria
Patent: 01150
Estimated Expiration: ⤷ Try a Trial
Patent: 52
Estimated Expiration: ⤷ Try a Trial
Brazil
Patent: 0508758
Estimated Expiration: ⤷ Try a Trial
Canada
Patent: 57845
Estimated Expiration: ⤷ Try a Trial
Patent: 74121
Estimated Expiration: ⤷ Try a Trial
Patent: 13355
Estimated Expiration: ⤷ Try a Trial
China
Patent: 60994
Estimated Expiration: ⤷ Try a Trial
Patent: 1812065
Estimated Expiration: ⤷ Try a Trial
Patent: 2127086
Estimated Expiration: ⤷ Try a Trial
Patent: 2838607
Estimated Expiration: ⤷ Try a Trial
Patent: 2887903
Estimated Expiration: ⤷ Try a Trial
Costa Rica
Patent: 93
Estimated Expiration: ⤷ Try a Trial
Patent: 110376
Estimated Expiration: ⤷ Try a Trial
Croatia
Patent: 0110425
Estimated Expiration: ⤷ Try a Trial
Patent: 0150358
Estimated Expiration: ⤷ Try a Trial
Patent: 0160223
Estimated Expiration: ⤷ Try a Trial
Patent: 0160885
Estimated Expiration: ⤷ Try a Trial
Patent: 0180407
Estimated Expiration: ⤷ Try a Trial
Cyprus
Patent: 11487
Estimated Expiration: ⤷ Try a Trial
Patent: 16327
Estimated Expiration: ⤷ Try a Trial
Patent: 17228
Estimated Expiration: ⤷ Try a Trial
Patent: 17841
Estimated Expiration: ⤷ Try a Trial
Patent: 20171
Estimated Expiration: ⤷ Try a Trial
Denmark
Patent: 30151
Estimated Expiration: ⤷ Try a Trial
Patent: 05683
Estimated Expiration: ⤷ Try a Trial
Patent: 16837
Estimated Expiration: ⤷ Try a Trial
Patent: 19846
Estimated Expiration: ⤷ Try a Trial
Patent: 26132
Estimated Expiration: ⤷ Try a Trial
Patent: 0700214
Estimated Expiration: ⤷ Try a Trial
Ecuador
Patent: 066953
Estimated Expiration: ⤷ Try a Trial
Eurasian Patent Organization
Patent: 3208
Estimated Expiration: ⤷ Try a Trial
Patent: 0601520
Estimated Expiration: ⤷ Try a Trial
European Patent Office
Patent: 30151
Estimated Expiration: ⤷ Try a Trial
Patent: 05683
Estimated Expiration: ⤷ Try a Trial
Patent: 11839
Estimated Expiration: ⤷ Try a Trial
Patent: 14589
Estimated Expiration: ⤷ Try a Trial
Patent: 16837
Estimated Expiration: ⤷ Try a Trial
Patent: 19846
Estimated Expiration: ⤷ Try a Trial
Patent: 26132
Estimated Expiration: ⤷ Try a Trial
Finland
Patent: 0070284
Estimated Expiration: ⤷ Try a Trial
Patent: 43
Estimated Expiration: ⤷ Try a Trial
Georgia, Republic of
Patent: 0094655
Estimated Expiration: ⤷ Try a Trial
Germany
Patent: 2005021371
Estimated Expiration: ⤷ Try a Trial
Patent: 2005026786
Estimated Expiration: ⤷ Try a Trial
Hong Kong
Patent: 98745
Estimated Expiration: ⤷ Try a Trial
Patent: 55728
Estimated Expiration: ⤷ Try a Trial
Patent: 55729
Estimated Expiration: ⤷ Try a Trial
Hungary
Patent: 28233
Estimated Expiration: ⤷ Try a Trial
Patent: 29913
Estimated Expiration: ⤷ Try a Trial
Patent: 36451
Estimated Expiration: ⤷ Try a Trial
Israel
Patent: 8038
Estimated Expiration: ⤷ Try a Trial
Patent: 3889
Estimated Expiration: ⤷ Try a Trial
Patent: 3890
Estimated Expiration: ⤷ Try a Trial
Patent: 4050
Estimated Expiration: ⤷ Try a Trial
Patent: 5298
Estimated Expiration: ⤷ Try a Trial
Patent: 1117
Estimated Expiration: ⤷ Try a Trial
Japan
Patent: 12294
Estimated Expiration: ⤷ Try a Trial
Patent: 18223
Estimated Expiration: ⤷ Try a Trial
Patent: 78486
Estimated Expiration: ⤷ Try a Trial
Patent: 43991
Estimated Expiration: ⤷ Try a Trial
Patent: 03392
Estimated Expiration: ⤷ Try a Trial
Patent: 07531756
Estimated Expiration: ⤷ Try a Trial
Patent: 11157370
Estimated Expiration: ⤷ Try a Trial
Patent: 12072162
Estimated Expiration: ⤷ Try a Trial
Patent: 12188439
Estimated Expiration: ⤷ Try a Trial
Patent: 14139205
Estimated Expiration: ⤷ Try a Trial
Patent: 15187134
Estimated Expiration: ⤷ Try a Trial
Patent: 17125052
Estimated Expiration: ⤷ Try a Trial
Patent: 18184462
Estimated Expiration: ⤷ Try a Trial
Lithuania
Patent: 14589
Estimated Expiration: ⤷ Try a Trial
Patent: 16837
Estimated Expiration: ⤷ Try a Trial
Malaysia
Patent: 3205
Estimated Expiration: ⤷ Try a Trial
Patent: 4985
Estimated Expiration: ⤷ Try a Trial
Patent: 2063
Estimated Expiration: ⤷ Try a Trial
Mexico
Patent: 3228
Estimated Expiration: ⤷ Try a Trial
Patent: 20008878
Estimated Expiration: ⤷ Try a Trial
Montenegro
Patent: 299
Estimated Expiration: ⤷ Try a Trial
Patent: 411
Estimated Expiration: ⤷ Try a Trial
Patent: 482
Estimated Expiration: ⤷ Try a Trial
Patent: 068
Estimated Expiration: ⤷ Try a Trial
Morocco
Patent: 492
Estimated Expiration: ⤷ Try a Trial
New Zealand
Patent: 9430
Estimated Expiration: ⤷ Try a Trial
Patent: 1326
Estimated Expiration: ⤷ Try a Trial
Patent: 2862
Estimated Expiration: ⤷ Try a Trial
Norway
Patent: 7669
Estimated Expiration: ⤷ Try a Trial
Patent: 064935
Estimated Expiration: ⤷ Try a Trial
Peru
Patent: 050880
Estimated Expiration: ⤷ Try a Trial
Poland
Patent: 30151
Estimated Expiration: ⤷ Try a Trial
Patent: 05683
Estimated Expiration: ⤷ Try a Trial
Patent: 16837
Estimated Expiration: ⤷ Try a Trial
Patent: 19846
Estimated Expiration: ⤷ Try a Trial
Patent: 26132
Estimated Expiration: ⤷ Try a Trial
Portugal
Patent: 30151
Estimated Expiration: ⤷ Try a Trial
Patent: 05683
Estimated Expiration: ⤷ Try a Trial
Patent: 16837
Estimated Expiration: ⤷ Try a Trial
Patent: 19846
Estimated Expiration: ⤷ Try a Trial
Patent: 26132
Estimated Expiration: ⤷ Try a Trial
Serbia
Patent: 693
Estimated Expiration: ⤷ Try a Trial
Patent: 891
Estimated Expiration: ⤷ Try a Trial
Patent: 598
Estimated Expiration: ⤷ Try a Trial
Patent: 941
Estimated Expiration: ⤷ Try a Trial
Patent: 000
Estimated Expiration: ⤷ Try a Trial
Singapore
Patent: 0735
Estimated Expiration: ⤷ Try a Trial
Patent: 0736
Estimated Expiration: ⤷ Try a Trial
Patent: 201406658V
Estimated Expiration: ⤷ Try a Trial
Slovenia
Patent: 30151
Estimated Expiration: ⤷ Try a Trial
Patent: 05683
Estimated Expiration: ⤷ Try a Trial
Patent: 16837
Estimated Expiration: ⤷ Try a Trial
Patent: 19846
Estimated Expiration: ⤷ Try a Trial
Patent: 26132
Estimated Expiration: ⤷ Try a Trial
South Africa
Patent: 0607181
Estimated Expiration: ⤷ Try a Trial
South Korea
Patent: 0930730
Estimated Expiration: ⤷ Try a Trial
Patent: 0993911
Estimated Expiration: ⤷ Try a Trial
Patent: 1200700
Estimated Expiration: ⤷ Try a Trial
Patent: 1410141
Estimated Expiration: ⤷ Try a Trial
Patent: 070022033
Estimated Expiration: ⤷ Try a Trial
Patent: 090104145
Estimated Expiration: ⤷ Try a Trial
Patent: 100069719
Estimated Expiration: ⤷ Try a Trial
Patent: 110110377
Estimated Expiration: ⤷ Try a Trial
Patent: 120046309
Estimated Expiration: ⤷ Try a Trial
Patent: 120106784
Estimated Expiration: ⤷ Try a Trial
Patent: 130020962
Estimated Expiration: ⤷ Try a Trial
Patent: 140021716
Estimated Expiration: ⤷ Try a Trial
Patent: 140133615
Estimated Expiration: ⤷ Try a Trial
Patent: 150046393
Patent: 25 PPM 미만의 14-하이드록시코데이논을 가지는 염산 옥시코돈의 제조방법 (PROCESS FOR PREPARING OXYCODONE HYDROCHLORIDE HAVING LESS THAN 25 PPM 14-HYDROXYCODEINONE)
Estimated Expiration: ⤷ Try a Trial
Patent: 180088505
Patent: 25 PPM 미만의 14-하이드록시코데이논을 가지는 염산 옥시코돈의 제조방법 (25 14- PROCESS FOR PREPARING OXYCODONE HYDROCHLORIDE HAVING LESS THAN 25 PPM 14-HYDROXYCODEINONE)
Estimated Expiration: ⤷ Try a Trial
Patent: 200000499
Patent: 25 PPM 미만의 14-하이드록시코데이논을 가지는 염산 옥시코돈의 제조방법 (25 14- PROCESS FOR PREPARING OXYCODONE HYDROCHLORIDE HAVING LESS THAN 25 PPM 14-HYDROXYCODEINONE)
Estimated Expiration: ⤷ Try a Trial
Spain
Patent: 62282
Estimated Expiration: ⤷ Try a Trial
Patent: 35618
Estimated Expiration: ⤷ Try a Trial
Patent: 66363
Estimated Expiration: ⤷ Try a Trial
Patent: 85576
Estimated Expiration: ⤷ Try a Trial
Patent: 65287
Estimated Expiration: ⤷ Try a Trial
Patent: 38727
Estimated Expiration: ⤷ Try a Trial
Taiwan
Patent: 65880
Estimated Expiration: ⤷ Try a Trial
Patent: 83944
Estimated Expiration: ⤷ Try a Trial
Patent: 0540177
Estimated Expiration: ⤷ Try a Trial
Patent: 1231469
Estimated Expiration: ⤷ Try a Trial
Patent: 1509943
Estimated Expiration: ⤷ Try a Trial
Tunisia
Patent: 06312
Estimated Expiration: ⤷ Try a Trial
Ukraine
Patent: 411
Estimated Expiration: ⤷ Try a Trial
Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.
See the table below for additional patents covering TARGINIQ around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Georgia, Republic of | P20074022 | PHARMACEUTICAL FORMULATIONS COMPRISING OXYCODONE AND NALOXONE | ⤷ Try a Trial |
Germany | 60325567 | ⤷ Try a Trial | |
Hong Kong | 1155729 | 製備含有低於 -羥基可待因酮的鹽酸羥考酮的方法 (PROCESS FOR PREPARING OXYCODONE HYDROCHLORIDE HAVING LESS THAN 25PPM 14- HYDROXYCODEINONE 25PPM 14-) | ⤷ Try a Trial |
European Patent Office | 1492505 | PREPARATION PHARMACEUTIQUE CONTENANT OXYCODONE ET NALOXONE (PHARMACEUTICAL PREPARATION CONTAINING OXYCODONE AND NALOXONE) | ⤷ Try a Trial |
Cyprus | 1119120 | ⤷ Try a Trial | |
Finland | U20070284 | ⤷ Try a Trial | |
European Patent Office | 2311438 | Matrices pour liberation modifee des agents actives (Matrix for sustained, invariant and independent release of active compounds) | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for TARGINIQ
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1685839 | CA 2013 00052 | Denmark | ⤷ Try a Trial | PRODUCT NAME: KOMBINATION AF OXYCODON SOM KOMPONENT A OG NALOXON SOM KOMPONENT B, HERUNDER OXYCODONHYDROCHLORID OG NALOXONHYDROCHLORIDDIHYDRAT; NAT. REG. NO/DATE: 43673, 43674 20081117; FIRST REG. NO/DATE: DE 64537.00.00, 64538.00.00, 64540.00.00, 64541.00.00 20060530 |
1685839 | 92292 | Luxembourg | ⤷ Try a Trial | PRODUCT NAME: COMBINAISON D OXYCODONE EN TANT QUE COMPOSANT A ET DE NALOXONE EN TANT QUE COMPOSANT B SOUS TOUTES LES FORMES PROTEGES PAR LE BREVET DE BASE |
1685839 | 122013000082 | Germany | ⤷ Try a Trial | PRODUCT NAME: KOMBINATION VON OXYCODON ALS KOMPONENTE A UND NALOXON ALS KOMPONENTE B IN ALLEN DEM SCHUTZ DES GRUNDPATENTS UNTERLIEGENDEN FORMEN; REGISTRATION NO/DATE: 64537.00.00 64538.00.00 64540.00.00 64541.00.00 73083.00.00 73084.00.00 73085.00.00 73086.00.00 20060530 |
1685839 | C300619 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: EEN COMBINATIE VAN OXYCODON ALS COMPONENT A EN NALOXON ALS COMPONENT B IN ALLE VORMEN ZOALS DEZE DOOR HET BASIS OCTROOI ONDER BESCHERMING WORDEN GESTELD; REGISTRATION NO/DATE: 64537.00.00 64538.00.00 64540.00.00 64541.00.00 20060530 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |